Regulation of glucagon-like peptide-1 sensitivity by gut microbiota dysbiosis

J Diabetes Investig. 2018 Mar;9(2):262-264. doi: 10.1111/jdi.12762. Epub 2017 Dec 1.

Abstract

Gut microbiota dysbiosis reduces expression of GLP-1 receptor (GLP-1R) and neuronal nitric oxide synthase (nNOS) in the enteric nervous system and hampers GLP-1-induced nitric oxide (NO) production through a pattern recognition receptor (PRR)-dependent mechanism, hence preventing activation of the gut-brain-periphery axis for control of insulin secretion and gastric emptying.

MeSH terms

  • Animals
  • Dysbiosis / metabolism*
  • Enteric Nervous System / metabolism
  • Enteric Nervous System / microbiology
  • Gastrointestinal Microbiome*
  • Glucagon-Like Peptide 1 / metabolism*
  • Humans
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type I / metabolism

Substances

  • Nitric Oxide
  • Glucagon-Like Peptide 1
  • Nitric Oxide Synthase Type I